Abstract. Non-small cell lung cancer (NSCLC) cells are relatively resistant to ionizing radiation (IR). The phosphatidylinositol 3 (PI3) kinases are members of a family of lipid kinases that mediate cellular functions, including cell growth, proliferation and DNA repair, which may contribute to radioresistance. We studied whether inhibition of PI3 kinases could increase the response of NSCLC cells to Á-irradiation. The results showed that pretreatment of PI3 kinase inhibitor wortmannin dose-dependently radiosensitized NSCLC A549 and H1650 cells by inhibiting colony formation, which was due to enhanced G2/M arrest and apoptosis by wortmannin. The accelerated apoptosis was accompanied by increased loss of mitochondrial membrane potential (MMP) and cytochrome c release to the cytoplasm. In addition, wortmannin pretreatment significantly increased caspase-3 activation, which was associated with the repression of X-linked inhibitor of apoptosis protein (XIAP). The radiosensitizing effect of wortmannin was correlated with the inhibition of phosphorylated PKB/Akt level. Furthermore, wortmannin down-regulated the expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) which is involved in DNA double stand break (DSB) repair, as a result, leading to the inhibition of DSBs rejoining, as indicated by increased level of Á-H2AX at 24 h after IR. Taken together, our results demonstrate that wortmannin acts as a powerful radiosensitizer in NSCLC cells by inhibiting PI3K/Akt survival signaling and DNA repair protein DNA-PKcs, suggesting that PI3 kinase inhibitors may represent a novel strategy for overcoming resistance to IR-induced apoptosis in NSCLC cells.
Introduction
Lung cancer is the leading cause of cancer mortality in the world. Radiotherapy by gamma-radiation plays a major role in the local treatment of NSCLC patients by inducing DNA damage, triggering cell cycle arrest and apoptosis (1, 2) . However, in clinical treatment, most NSCLC patients respond poorly to conventional radiotherapy because of the emergence of resistance for reasons including defects in the apoptotic machinery (3) and overexpression of genes related to cell survival (4, 5) . Hence there is an urgent need to develop novel strategies to overcome the resistance and improve outcome of NSCLC treatment.
The phosphoinositide-3-kinase (PI3K) pathway is frequently up-regulated in human tumors (6) . Elevated levels of phosphorylated PKB/Akt, the major downstream effector of PI3K, can protect cells from undergoing apoptosis by down-regulation of the pro-apoptotic Bcl-2 family and upregulation of the anti-apoptotic c-FLIP, IAPs and Bcl-2 family proteins (7), leading to increased cell survival. DNAdependent protein kinase (DNA-PK), another member of PI3 kinase family, is a nuclear serine/threonine protein kinase essential for DNA repair as well as sensing and transmitting a damage signal to downstream targets, leading to cell cycle arrest and DNA repair, thus contributing to drug resistance (8, 9) .
Therefore, inhibition of PI3 kinases by pharmacological approach may improve the response of cancer cells to radiotherapy. Wortmannin is a widely used inhibitor of PI3 kinases (10) . Wortmannin has been reported to have radiosensitization effects in RT112 bladder tumor cells (11) and BT-474 cells breast cancer cells (12) in vitro, and C3H/HeJ hepatocarcinoma (13) in vivo. For NSCLC cells, Sak et al (14) reported that the inhibition of DNA-dependent protein kinase activity with antisense-oligodeoxynucleotide (As-ODN) or wortmannin led to marked inhibition of DNA double strand breaks (DSBs) rejoining and radiosensitization of ONCOLOGY REPORTS 24: 1683 -1689 , 2010 Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation TAO In the current study, we investigated the effects of wortmannin on the response to Á-irradiation in NSCLC cells in vitro. We demonstrate that wortmannin acts as a powerful radiosensitizer in NSCLC cells in vitro by enhancing G2/M arrest and promoting apoptosis. The enhanced apoptosis was accompanied by mitochondrial injury, caspase-3 activation and decreased DSBs repair. The radiosensitizing effect by wortmannin was correlated with its inhibition of Akt phosphorylation and the DNA repair protein DNA-PKcs. Based on these findings, we conclude that combining PI3K inhibitors and Á-irradiation may present promising strategy for clinical treatment of human NSCLC.
Materials and methods
Cell culture and treatments. NSCLC cells A549 and H1650 were grown in Dulbecco's modified Eagle's medium (DMEM, Gibco, USA) supplemented with 10% fetal bovine serum, 10 mg/ml antibiotics (penicillin and streptomycin) and 2 mmol/l L-glutamine at 37˚C under 5% CO 2 and saturated moisture. Wortmannin (Sigma, St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO, Sigma), final concentrations of 1, 5 and 20 μM were used to treat the cells and proper amount of DMSO was used as vehicle control.
Clonogenic assay. Cells were divided into the following groups: control (cells were treated with DMSO as vehicle control), WM+IR (cells were treated with 1, 5 or 20 μM wortmannin for 1 h followed by IR 5 Gy), IR (cells were treated with DMSO followed by IR 5 Gy), WM (cells were treated with wortmannin 20 μM). Following different treatments, cells were incubated for 24 h. Thereafter, cells were trypsinized and seeded in triplicate in 60-mm dishes (500 cells per dish) and incubated for 14 days to allow for colony growth. Colonies of >50 cells were counted manually using a microscope.
Cell cycle analysis. At the time of harvesting, cells were digested with 0.25% trypsin (Gibco) and re-suspended in phosphate-buffered saline (PBS), fixed in 70% ethanol at 4˚C overnight. When analyzing, cells were washed with PBS and treated with 20 μg/ml ribonuclease A (RNase A, Sigma) at 37˚C for 30 min. Cells were then stained with 50 μg/ml propidium iodide (PI, Sigma) for 30 min in the dark. 
Assessment of changes of mitochondrial membrane potential (MMP)
. MMP was measured by flow cytometry with MitoTracker Red (Invitrogen) probe, a mitochondrionselective stain that is concentrated in active mitochondria, while the reduction of MMP leads to the release of the stain. The probe was dissolved in DMSO and diluted in PBS before treatment. Cells were treated with MitoTracker for 45 min before trypsinization, then washed twice with PBS and analyzed by flow cytometry on a FACScan station with CellQuest software using the FL2 for MitoTracker Red staining.
Analysis of active caspase-3. Cells were collected by trypsin and the experiments were performed following the manual. Briefly, cells were fixed and permeabilized using the Cytofix/ Cytoperm™ kit (BD Pharmingen) for 20 min at RT, pelleted and washed with Perm/Wash™ buffer (BD Pharmingen). Cells were then stained with FITC labeled anti-caspase-3 active form (BD Pharmingen) for 60 min at RT in the dark. Samples were analyzed by flow cytometry on a FACScan station with CellQuest software using the FL1 for FITC labeled caspase-3 active form.
Western blotting. Cells were rinsed in PBS and then lysed in lysis buffer containing 150 mM NaCl, 1% NP40, 0.5% deoxycholic acid, 0.1% SDS, 50 mM Tris (pH 8.0) and 1:25 protease inhibitor cocktail. The lysates were kept on ice for 30 min before centrifuging at 14000 rpm to remove any cellular debris. For cellular fractionation, cells were washed with PBS and lysed in cytosolic lysis buffer containing 250 mM sucrose, 70 mM KCl, 137 mM NaCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 (pH 7.2), 200 μg/ml digitonin, 100 mM PMSF and 1:25 protease inhibitor cocktail for 30 min on ice. Cells were centrifuged at 14000 rpm for 15 min at 4˚C. The supernatant was saved as cytosolic protein extract. Protein concentrations of the lysates were determined by the Bradford protein assay system (Bio-Rad, Hercules, CA). Equal amounts of protein (20 μg protein each lane) were separated by SDS-PAGE, transferred to nitrocellulose membranes (Hybond C, Amersham, UK). Immunoblots were blocked with 5% skim milk in TBS/Tween-20 (0.05%, v/v) for 1 h at RT. The membrane was incubated with primary antibody overnight at 4˚C. Antibodies against cytochrome c, total AKT (t-Akt), phospho-AKT (p-Akt) and PARP were from BD Pharmingen, antibodies against XIAP and DNA-PK catalytic subunit (DNA-PKcs) were from BD transduction laboratories, and ß-actin antibody was purchased from Sigma. Following several washes with PBS containing 0.1% Tween-20, the membrane was incubated with corresponding secondary antibody conjugated with horseradish peroxidase (Sigma), diluted in 5% skim milk (1:5000) at RT for 1 h. The blots were developed using an enhanced chemiluminescence Western blotting detection system (Amersham Bioscience, UK).
Statistical analysis. The data represent at least three independent experiments. Statistical comparisons were made using Student's t-test. P<0.05 was considered to represent a stati-stically significant difference.
Results

Pretreatment of wortmannin radiosensitizes NSCLC cells by inhibiting colony formation. NSCLC A549 and H1650 cells
were incubated with different concentrations of wortmannin for 1 h followed by 5 Gy Á-irradiation. Clonogenic assay was performed 14 days after cell plating. The results (Fig. 1) showed that 5 Gy IR modestly inhibit colony formation in both cell lines. Wortmannin pretreatment significantly enhanced the inhibitory effect of 5 Gy IR in both cell lines in a dose-dependent way. The highest concentration of wortmannin (20 μM) showed the best synergistic effects for increasing the radiosensitivity of NSCLC cells, while had no effect on colony formation when used alone, compared with vehicle control.
Pretreatment with wortmannin enhances IR-induced G2/M arrest and apoptosis.
We then studied whether wortmannin had any effects on IR-caused cell cycle changes and apoptosis in A549 cells. We chose wortmannin 20 μM to pretreat the cells according to the results of clonogenic assay. Cell cycle was detected by flow cytometry at 24 h after 5 Gy IR. The results ( Fig. 2A and B) showed that IR caused cell cycle arrest in G2/M phase, which could be enhanced by wortmannin pretreatment, while wortmannin alone had no effect on cell cycle changes. Apoptosis was detected by Annexin V/PI staining with flow cytometry. The results (Fig. 2C) showed that cells treated with 5 Gy IR had only small amount of Annexin V positive cells. However, when cells were pretreated with wortmannin, much more apoptotic cells were observed compared to IR alone. Wortmannin itself had no effect on apoptosis compared to vehicle control. Taken together, these results indicate that wortmannin radiosensitizes NSCLC cells by enhancing G2/M cell cycle arrest and apoptosis.
Effects of wortmannin on Akt phosphorylation in NSCLC cells. Akt phosphorylation by PI3K pathway is implicated in mediating cell survival and protecting cells from apoptosis. To demonstrate that wortmannin promotes IR-induced apoptosis by repressing the PKB/Akt surviving signalling, we measured total and phosphorylated levels of Akt. The results showed that wortmannin 20 μM caused a decrease of phosphorylated Akt, without affecting total Akt level. Irradiation with 5 Gy Á-ray did not change total or phosphorylated Akt level, while wortmannin pretreatment followed by IR resulted in decreased Akt phosphorylation (Fig. 3) . The reduction of phosphorylated PKB/Akt level correlated with the enhancement of IR-induced apoptosis, as indicated by Annexin V-positive cells analyzed by flow cytometry (Fig. 2C) .
Wortmannin increases IR-induced loss of MMP and cytochrome c release.
The loss of MMP plays a pivotal role in the initiation of apoptosis, resulting in the release of key apoptosis mediators such as cytochrome c (15) , which leads to the activation of apoptosis signaling cascades. Therefore, we investigated whether wortmannin could increase the activation of mitochondrial pathway by measuring MMP changes and cytochrome c release in the cytoplasm. The results (Fig. 4A and B) showed that IR treatment caused a decrease of MMP compared to vehicle control, while wortmannin had no effect on MMP. However, pretreatment with wortmannin markedly increased IR-induced MMP dissipation. Consistently, cytochrome c release was significantly increased in radiated cells with wortmannin pretreatment compared to IR alone, while wortmannin itself did not cause cytochrom c release (Fig. 4C) . These data suggest that wortmannin radiosensitizes NSCLC cells by enhancing the mitochondrial apoptotic pathway.
Wortmannin promotes IR-induced caspase-3 activation.
Caspase-3 is a key protease of caspase family which plays an important role in apoptosis. Active caspase-3 is the executor of apoptotic event, which is derived from the 32-kDa protein and consists of a heterodimer of 17 and 12 kDa subunits. We measured active caspase-3 level with flow cytometry. The results (Fig. 5A and B) showed that wortmannin 20 μM alone had no effects on caspase-3 activation, however, it enhanced the effects of IR by causing increased level of active caspase-3. The anti-apoptotic XIAP protein is responsible for inhibiting apoptosis by directly binding and inhibiting caspase-3 activation (16) . Using Western blotting, we observed that pretreatment with wortmannin markedly reduced XIAP expression compared to IR alone (Fig. 5C ), which were consistent with the changes of caspase-3 activity.
Since caspase-3 proteolytically cleaves its target PARP, we performed Western blot analysis to detect PARP cleavage to further verify the induction of caspase-3 activity and apoptosis. During apoptosis, PARP is cleaved from its 116 kDa intact form into 85 and 25 kDa fragments by caspase-3. The results showed that pretreatment with wortmannin caused more cleavage of PARP in radiated cells, compared to IR alone, as indicated by a much stronger 85 kDa-band (Fig.  5C ). These results demonstrate that increased activation of caspase-3, which may be the consequence of XIAP repression, contri-butes to wortmannin-induced radiosensitivity.
Wortmannin pretreatment radiosensitizes A549 cells through down-regulation of DNA-PKcs and inhibition of DSBs rejoining.
In cancer cells, efficient DNA repair activity is considered to be an important reason for radiotherapeutic resistance (17) . WM binds to the kinase domain of DNA- PKcs and inhibits DNA-PK function in vitro and in vivo (18) . Its sensitizing effect most likely results from the inhibition of DSBs repair, specifically non-homologous end joining (NHEJ) (19) , which is known to be one of the major DNA DSB repair pathways in mammalian cells. We analyzed the effects of wortmannin pretreatment in radiated cells by Western blotting, on the expression of DNA-PKcs and Á-H2AX, a marker of DSBs. As shown in Fig. 6 , DNA-PKcs was slightly increased at 24 h after IR, suggesting the activation of DNA repair system after IR. Wortmannin alone or with IR downregulated the expression of DNA-PKcs, leading to an enhanced expression of Á-H2AX at 24 h after IR. These results suggest that repressed DNA repair may be a mechanism by which wortmannin induces radiosensitivity in NSCLC cells.
Discussion
Radiotherapy with Á-irradiation is the major therapeutic option in cancer treatment. However, many tumors have shown radioresistance which greatly limits the effect of radiotherapy. Cancer cells tend to be resistant to radiotherapy due to defects in apoptosis, overexpression of genes related to cell survival (4), and enhanced DNA repair activity. It has been demonstrated that NSCLC cells have up-regulated level of PI3K/Akt pathway (20) which is implicated in radioresistance. In the current study, we observed that inhibition of PI3K signaling by wortmannin radiosensitized NSCLC cells by significantly decreasing the colony formation ability in these cells. The enhanced growth inhibition was due to G2/M cell cycle arrest and apoptosis, which was accompanied by inhibition of Akt phosphorylation. Akt activation by phosphorylation has been demonstrated to deliver anti-apoptotic survival signals through phosphorylation of proapoptotic proteins such as BAD (21) and Bax (22) . Akt phosphorylates Bax at Ser 184 , leading to Bax inactivation (23) . Bax activation includes Bax oligomerization and subsequent translocation. Bax oligomerization has also been proposed to facilitate the de novo pore formation or the opening of the existing channels in the outer mitochondrial membrane, allowing the release of cytochrome c in the cytoplasm (24) . In the present study, we showed that wortmannin enhanced IR-induced dissipation of MMP. Loss of MMP is an early sign of mitochondrial injury, which induces the permeabilization of mitochondrial membrane that facilitates the release of critical proapoptotic proteins from the mitochondria into the cytoplasm, including cytochrome c, leading to the activation of caspase-9 and downstream cleavage of caspase-3. As expected, increased cytochrome c release in the cytoplasm was observed with wortmannin pretreatment. Subsequently, caspase-3 activation was greatly increased as indicated by the level of the active form of caspase-3, which is the executor of apoptosis. XIAP belongs to the inhibitor of apoptosis proteins (IAPs) family. IAPs are overexpressed in many cancers and implicated in tumor pathogenesis, growth, and resistance to chemo-or radiotherapy. XIAP is the most potent caspase inhibitor in this family (25) . Uchida et al (26) have reported that PI3K inhibitors wortmannin and LY294002 down-regulate XIAP expression, which is one of the mecha-nisms mediating the enhanced susceptibility to TRAIL-induced apoptosis in oral squamous carcinoma cells. Here, we also showed that wortmannin down-regulated XIAP expression in NSCLC A549 cells, leading to increased caspase-3 activation and, as a consequence, wortmannin dramatically enhanced IR-induced apoptosis.
IR causes DNA double-strand breaks (DSBs), one of the most fatal forms of DNA damage. There are two ways to repair DNA DSBs in eukaryotic cells: homologous recombination (HR) and non-homologous end-joining (NHEJ) (27) . Ativation of DNA repair activity of cancer cells after DNA damage caused by IR might be one reason for radioresistance (28) . The NHEJ pathway of DNA DSBs is initiated by the DNA-PK complex, which consists of DNA-PK catalytic subunit (DNA-PKcs), and the Ku DNA-binding subunits, Ku70 and Ku80 (29) . It has been shown that inhibition or deletion of DNA-PKcs renders cells highly sensitive to DSBs induced by IR and DNA damaging agents (30) . DNAPKcs is a member of a subfamily of proteins containing the phosphatidylinositol (PI)-3 kinase domain, which could be inhibited by wortmannin. Ortiz et al (11) have reported that WM-dependent radiosensitization in RT112 radioresistant bladder tumor cells is a direct consequence of the inhibition of DNA-PK, resulting in the inhibition of DSB repair, suggesting that the expression level of DNA-PKcs in human tumor cells may be a good predictor for the success of DNAPKcs inhibitors when used as radiosensitizers. In vivo assays revealed that wortmannin, in combination with radiation therapy, may have potential benefits in cancer treatment for C3H/HeJ hepatocarcinoma (13). Sak et al (14) reported that the inhibition of DNA-dependent protein kinase activity by wortmannin led to marked inhibition of the rejoining of DNA double strand breaks (DSBs). We confirmed that in NSCLC A549 cells, wortmannin repressed DNA-PKcs, as a consequence, DNA DSBs repair activity was inhibited, as indicated by an enhanced expression of Á-H2AX 24 h after IR. Yan et al (31) observed that vanillin derivative bromovanin induced apoptosis in Jurkat cells via mechanisms including cleavage of DNA-PKcs and subsequent increase of DNA DSBs and Akt inactivation. DNA-PKcs has been suggested to be a target for caspase-3 (31, 32) . We postulate based on the current results that the inactivation of DNA-PKcs might be through the direct inhibition of kinase activity by wortmannin and the degradation of DNA-PKcs by increased caspase-3 activity.
Taken together, the present study demonstrates that inhibition of PI3K/Akt cell survival signaling pathway and DNA repair protein DNA-PKcs may contribute to wortmannininduced radiosensitivity in NSCLC cells. Our results provide further support for a promising strategy combining PI3K inhibitors and Á-irradiation for clinical treatment of human NSCLC. Figure 6 . Wortmannin pretreatment down-regulated expression of DNAPKcs and inhibited DSBs rejoining. A549 cells were treated as described above and collected at 24 h after IR. Western blotting with anti-DNA-PKcs, Á-H2AX and Actin antibodies was performed.
